Noted for its ‘unparalleled’ knowledge of Polish reimbursement rules, the team at Baker McKenzie Krzyzowski i Wspólnicy Sp.k. is well placed to advise clients on product distribution schemes and the transf of reimbursement approvals. ’Skilled and bright’ team lead Juliusz Krzyżanowski is known for his expansive expertise in pricing and reimbursement issues within the pharmaceutical industry. Marcin Fiałka is particularly adept at handling matters involving pharmaceutical market regulations, dietary supplements, and medical devices, as well as advising on related data privacy procedures.
Testimonials
Collated independently by Legal 500 research team.
‘I really enjoy working with B&M in Poland. Juliusz Krzyżanowski is always willing to help. He keeps us updated on all new regulations that may affect our business, connects with his colleagues in other countries and is very responsive.’
‘The team has regulatory expertise with in-depth knowledge of pharmaceutical and reimbursement regulations. They are also excellent negotiators, and one can see their practical corporate background. They are familiar with market trends from the inside out. In this particular transaction everything was in a perfect setup and I knew that we are in good hands.’
Key clients
- Astellas Pharma
- Berlin-Chemie/Menarini
Work highlights
- Advised Izba Gospodarcza, FARMACJA POLSKA, on the legislative process pertaining to a major amendment to the Act on Reimbursement of Medicinal Products, Foodstuffs Intended for Special Nutritional Purposes and Medical Devices.
- Advised Swedish Orphan Biovitrum on the establishment of a distribution model for its newly launched product.